The carrying amount of goodwill was $512.9 million at both September 30, 2025 and December 31, 2024. Goodwill represents the excess purchase price over the fair value of net assets acquired. The annual impairment test was performed as of October 31, 2024. No impairment of goodwill was identified during 2024, nor has any impairment of goodwill been identified during the nine months ended September 30, 2025.


	As of September 30, 2025						As of December 31, 2024
	Gross Amount		Accumulated Amortization		Net Carrying Amount		Gross Amount		Accumulated Amortization		Net Carrying Amount
Customer relationships	$	—	$	—	$	—	$	1,495	$	(1,401)	$	94
Acquired technology	150,097		(129,303)		20,794		150,097		(112,791)		37,306

Capitalized software development costs	98,380		(36,857)		61,523		81,080		(23,847)		57,233
	$	248,477	$	(166,160)	$	82,317	$	232,672	$	(138,039)	$	94,633

The Company recorded intangible assets from various prior business combinations as well as capitalized software development costs. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which range from four to seven years. During the three months ended September 30, 2025 and 2024, the Company capitalized software development costs of $6.1 million and $6.5 million, respectively, and $17.7 million and $19.9 million for the nine months ended September 30, 2025 and 2024, respectively. Amortization expense included in cost of revenues on the condensed consolidated statements of comprehensive income (loss) was $10.1 million and $9.0 million for the three months ended September 30, 2025 and 2024, respectively, and $29.5 million and $25.9 million for the nine months ended September 30, 2025 and 2024, respectively. Amortization expense included in operating expenses on the condensed consolidated statements of comprehensive income (loss) was zero and $4.8 million for the three months ended September 30, 2025 and 2024, respectively, and $0.1 million and $14.4 million for the nine months ended September 30, 2025 and 2024, respectively.

During the period ended September 30, 2025, the Company recognized an impairment loss related to capitalized software development costs for certain software assets that are no longer expected to be recoverable. The Company calculated the impairment by comparing the carrying amount of the asset to its estimated fair value using a discounted cash flow model. As a result, the Company recorded an impairment charge of $0.4 million to research and development expense within the Company's condensed consolidated statements of comprehensive income (loss) during the three and nine months ended September 30, 2025.